Amyloid beta resistance in nerve cell lines is mediated by the warburg effect

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Newington, Jordan T ^a   Pitts, Andrea ^a   Chien, Andrew ^a   Arseneault, Robert ^a   Schubert, David ^b   Cumming, Robert C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; LACTATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE; REACTIVE OXYGEN METABOLITE; LACTIC ACID; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL TRANSFERRING) KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GLYCOLYSIS; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; WARBURG EFFECT; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL STRAIN; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MITOCHONDRION;

AMYLOID BETA-PEPTIDES; ANIMALS; GLYCOLYSIS; L-LACTATE DEHYDROGENASE; LACTIC ACID; MITOCHONDRIA; MODELS, BIOLOGICAL; NEURONS; PC12 CELLS; PROTEIN-SERINE-THREONINE KINASES; RATS; REACTIVE OXYGEN SPECIES;

EID: 79955629694     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019191     Document Type: Article

References (59)

1. Selkoe DJ, (2004) Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 140: 627-638.
2. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, et al. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82: 4245-4249.
3. Hardy J, (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20: 154-159.
4. Selkoe DJ, (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8: 447-453.
5. Behl C, (1997) Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 290: 471-480.
6. Behl C, Davis J, Cole GM, Schubert D, (1992) Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 186: 944-950.
7. Behl C, Davis JB, Lesley R, Schubert D, (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827.
8. Butterfield DA, Reed T, Newman SF, Sultana R, (2007) Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43: 658-677.
9. Markesbery WR, (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147.
10. Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH, (1994) Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4: 138-150.
11. Price JL, Morris JC, (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45: 358-368.
12. Sagara Y, Dargusch R, Klier FG, Schubert D, Behl C, (1996) Increased antioxidant enzyme activity in amyloid beta protein-resistant cells. J Neurosci 16: 497-505.
13. Dargusch R, Schubert D, (2002) Specificity of resistance to oxidative stress. J Neurochem 81: 1394-1400.
14. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D, (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39: 43-56.
15. Cumming RC, Dargusch R, Fischer WH, Schubert D, (2007) Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells. J Biol Chem 282: 30523-30534.
16. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, et al. (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271: 32529-32537.
17. Semenza GL, (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578.
18. Kim JW, Tchernyshyov I, Semenza GL, Dang CV, (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177-185.
19. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC, (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-197.
20. Semenza GL, (2007) HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 39: 231-234.
21. Semenza GL, (2010) HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20: 51-56.
22. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, et al. (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11: 37-51.
23. Michelakis ED, Webster L, Mackey JR, (2008) Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer 99: 989-994.
24. Gatenby RA, Gillies RJ, (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899.
25. Warburg O, (1956) On respiratory impairment in cancer cells. Science 124: 269-270.
26. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL, (2005) Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia 7: 1-6.
27. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, et al. (2010) Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med 2: 31ra34.
28. Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, et al. (2010) Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition. Proc Natl Acad Sci U S A 107: 17763-17767.
29. Bigl M, Bruckner MK, Arendt T, Bigl V, Eschrich K, (1999) Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J Neural Transm 106: 499-511.
30. Gibson GE, Sheu KF, Blass JP, (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105: 855-870.
31. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, et al. (2008) Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A 105: 4441-4446.
32. Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, et al. (2007) Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res 1127: 127-135.
33. Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA, (2002) Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 80: 91-100.
34. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, et al. (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. Faseb J 19: 2040-2041.
35. Zamzami N, Kroemer G, (2001) The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2: 67-71.
36. Greene LA, Tischler AS, (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73: 2424-2428.
37. Schubert D, Heinemann S, Carlisle W, Tarikas H, Kimes B, et al. (1974) Clonal cell lines from the rat central nervous system. Nature 249: 224-227.
38. Lamster IB, Hartley LJ, Oshrain RL, Gordon JM, (1985) Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival crevicular fluid collected with filter-paper strips. Arch Oral Biol 30: 235-242.
39. Itoh Y, Esaki T, Shimoji K, Cook M, Law MJ, et al. (2003) Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo. Proc Natl Acad Sci U S A 100: 4879-4884.
40. Hansen MB, Nielsen SE, Berg K, (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210.
41. Goldman RD, Kaplan NO, Hall TC, (1964) Lactic Dehydrogenase in Human Neoplastic Tissues. Cancer Res 24: 389-399.
42. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, et al. (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107: 2037-2042.
43. Fantin VR, St-Pierre J, Leder P, (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9: 425-434.
44. Cumming RC, Andon NL, Haynes PA, Park M, Fischer WH, et al. (2004) Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem 279: 21749-21758.
45. Yasykova MY, Petukhov SP, Muronetz VI, (2000) Phosphorylation of lactate dehydrogenase by protein kinases. Biochemistry (Mosc) 65: 1192-1196.
46. Cooper JA, Esch FS, Taylor SS, Hunter T, (1984) Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro. J Biol Chem 259: 7835-7841.
47. Fritz PJ, (1965) Rabbit muscle lactate dehydrogenase 5; a regulatory enzyme. Science 150: 364-366.
48. Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, et al. (2010) Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer 9: 33.
49. Schubert D, (2005) Glucose metabolism and Alzheimer's disease. Ageing Res Rev 4: 240-257.
50. Cardoso SM, Santos S, Swerdlow RH, Oliveira CR, (2001) Functional mitochondria are required for amyloid beta-mediated neurotoxicity. Faseb J 15: 1439-1441.
51. Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, et al. (2009) Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. Faseb J 23: 2459-2466.
52. McFate T, Mohyeldin A, Lu H, Thakar J, Henriques J, et al. (2008) Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J Biol Chem 283: 22700-22708.
53. Raichle ME, Posner JB, Plum F, (1970) Cerebral blood flow during and after hyperventilation. Arch Neurol 23: 394-403.
54. Boyle PJ, Scott JC, Krentz AJ, Nagy RJ, Comstock E, et al. (1994) Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest 93: 529-535.
55. Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, et al. (2007) Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc Natl Acad Sci U S A 104: 2945-2949.
56. Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, et al. (2010) Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci U S A 107: 17757-17762.
57. Lewerenz J, Dargusch R, Maher P, (2010) Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicity. J Neurochem 113: 502-514.
58. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, et al. (2007) Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 282: 10873-10880.
59. Wang R, Zhang YW, Zhang X, Liu R, Hong S, et al. (2006) Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. Faseb J 20: 1275-1277.